FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Intracranial Aneurysm Flow Diverter
PMA: P100018
·
Supplement: S043
·
Decision Jun 6, 2024
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Intracranial Aneurysm Flow Diverter
- Trade Name
- Pipeline Vantage Embolization Device with Shield Technology
- PMA Number
- P100018
- Supplement Number
- S043
- Device Class
- FDA Class 3
- Product Code
- OUT
- Generic Name
- Intracranial aneurysm flow diverter
- Medical Specialty
- Unknown
- Advisory Committee
- Neurology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 6, 2024
- Date Received
- October 13, 2023
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P100018/S034
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OUT | Intracranial Aneurysm Flow Diverter | FDA class 3 | Unknown |